FLUTE Cross-border Prostate Cancer Data Standard Guide, published by Flute Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/flute/ and changes regularly. See the Directory of published versions

• Content
• Detailed Descriptions
• Mappings
• XML
• JSON

Logical Model: Inclusion Criteria for Prostate Cancer Cohorts

Criteria for including men in cohorts based on clinical suspicion of prostate cancer.

Usage:

• This Logical Model Profile is not used by any profiles in this Implementation Guide

Formal Views of Profile Content

Description of Profiles, Differentials, Snapshots and how the different presentations work.

• Differential Table
• Key Elements Table
• Snapshot Table
• Statistics/References
• All

This structure is derived from Base

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

This structure is derived from Base

Summary

Differential View

This structure is derived from Base

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

Key Elements View

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

Snapshot View

Name	Flags	Card.	Type	Description & Constraints
InclusionCriterias		0..*	Base	Inclusion Criteria for Prostate Cancer Cohorts Instances of this logical model are not marked to be the target of a Reference
psa		0..1	Quantity	Level of prostate-specific antigen. The measurement of PSA levels in the blood, typically reported in ng/ml.
dre		0..1	integer	Results of digital rectal examination. Indicates the findings of the DRE (0: normal, 1: suspicious).
Documentation for this format

This structure is derived from Base

Summary

Other representations of profile: CSV, Excel